Clinical Trials Logo

Neoplasms, Endometrial clinical trials

View clinical trials related to Neoplasms, Endometrial.

Filter by:
  • None
  • Page 1

NCT ID: NCT02630823 Completed - Endometrial Cancer Clinical Trials

MK-3475 Immunotherapy in Endometrial Carcinoma

Start date: February 5, 2016
Phase: Phase 1
Study type: Interventional

Due to the high expression of PD-L1 in endometrial cancers as well as in ovarian cancers which are molecularly similar to uterine serous cancers, using pembrolizumab should be beneficial in this patient population. Since the investigators are able to get a pre-treatment research- related endometrial biopsy as well as the surgical specimen post two cycles of pembrolizumab, the investigators will be able to evaluate the mechanism of action of this drug on the endometrial cancer tumor environment.

NCT ID: NCT00377520 Completed - Neoplasms Clinical Trials

A Trial for Patients With Advanced/Recurrent Endometrial Cancer

Start date: September 2006
Phase: Phase 2
Study type: Interventional

The intent of this protocol is to screen a new agent for activity in patients with advanced or recurrent endometrial carcinoma. This phase II trial is studying how well pemetrexed disodium works in treating patients with advanced or recurrent endometrial carcinoma.

NCT ID: NCT00267488 Completed - Endometrial Cancer Clinical Trials

Intravenous Weekly Topotecan In Subjects With Recurrent Or Persistent Endometrial Cancer

Start date: October 2005
Phase: Phase 2
Study type: Interventional

The purpose of this study is to find out if Hycamtin given weekly is safe and effective for treating your endometrial cancer.